Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

GlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

The regulatory clearance for Alembic Pharma's Gujarat facility came without any observations. The USFDA had inspected the ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

Naqi Logix founder Dave Segal has invented a device that lets anyone control a computer with their head—no brain implant required.

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...

The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

Martha Sazon, ranked No. 38 on the Fortune Most Powerful Women Asia list this year, joined Mynt as president and CEO in June ...